October 2009 · Vol. 21, No. 10PELVIC FLOOR DYSFUNCTION
Two recent studies of overactive bladder and urge incontinence treatments address the value of behavioral management and oxybutynin’s impact on cognition in the elderly
|
Fast Track
Combining an anticholinergic and behavioral therapy may treat urge incontinence more effectively than either modality alone in women who are dissatisfied with single therapy
Oxybutynin for urge incontinence did not increase the rate of falls among subjects—cognitively impaired female residents of a nursing home
You can prescribe oxybutynin for urge incontinence in nursing home residents who exhibit some cognitive decline with little worry that the drug will accelerate that decline significantly
|
|
John
P.
Judd,
MDDr. Judd is a Fellow in Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC. Cindy
L.
Amundsen,
MDDr. Amundsen is Associate Professor and Fellowship Director, Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC.
The authors report no financial relationships relevant to this article.
Overactive bladder (OAB)—urinary urgency, with or without incontinence, usually with frequency and nocturia1—is a common problem among women who seek care from an ObGyn. In fact, the condition is estimated to carry a health-care cost in excess of $12 billion annually in the United States.2
|
